CALCITONIN THERAPY IN OSTEOPOROTIC SYNDROMES

Adinoff, 1983, Steroid-induced fractures and bone loss in patients with asthma, N Engl J Med, 309, 365, 10.1056/NEJM198308043090502 Arlot, 1993, Temporal variations in iliac trabecular bone formation in vertebral osteoporosis, Calcif Tissue Int, 52, 10, 10.1007/BF00675620 Arlot, 1990, Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: Comparison with normal postmenopausal women, Osteoporos Int, 1, 41, 10.1007/BF01880415 Avioli, 1988, Rationale for the use of calcitonin in postmenopausal osteoporosis, Ann Chir Gynaecol, 77, 224 Bagelos, 1957, Effect of sodiumphytate on the hypercalciuria of acute quadriplegia due to poliomyelitis, N Engl J Med, 256, 773, 10.1056/NEJM195704252561702 Bisson, 1982, Synthetic salmon calcitonin treatment of choice in Sudeck’s atrophy disease, Minerva Med, 63, 1065 Body, 1983, Estimates of circulating monomeric calcitonin: Physiological studies in normal and thyroidectomized man, J Clin Endocrinol Metab, 57, 897, 10.1210/jcem-57-5-897 Burckhardt, 1993, The effect of treatment with calcitonin on vertebral fracture rate in osteoporosis, Osteoporos Int, 3, 24, 10.1007/BF01623173 Camporeale, 1993, Treatment of postmenopausal osteoporosis with intranasal salmon calcitonin: Doses and cycles [Abstract 77] Carstens, 1991, Future horizons for calcitonin: A US perspective, Calcif Tissue Int, 49, S2, 10.1007/BF02561368 Chantraine, 1979, Bone metabolism, parathyroid hormone, and calcitonin in paraplegia, Calcif Tissue Int, 27, 199, 10.1007/BF02441186 Chantraine, 1986, Bone remodeling during the development of osteoporosis in paraplegia, Calcif Tissue Int, 38, 323, 10.1007/BF02555744 Civitelli, 1988, Bone turnover in postmenopausal osteoporosis, J Clin Invest, 82, 1268, 10.1172/JCI113725 Donaldson, 1970, Effect of prolonged bed rest on bone mineral, Metabolism, 19, 1071, 10.1016/0026-0495(70)90032-6 Drinkwater, 1990, Menstrual history as a determinant of current bone density in young athletes, JAMA, 263, 545, 10.1001/jama.1990.03440040084033 Ettinger, 1985, Long-term estrogen replacement therapy prevents bone loss and fractures, Ann Intern Med, 102, 319, 10.7326/0003-4819-102-3-319 Eufemio, 1990, Advances in the therapy of osteoporosis. Steroid-induced osteoporosis, Geriatr Med Today, 9, 41 Fiore, 1983, Antalgic activity of calcitonin: Effectiveness of the epidermal and subarachnoid routes in man, British Journal of Clinical Pharmacologic Research, 3, 257 Gennari, 1992, An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss, Calcif Tissue Int, 50, 381, 10.1007/BF00301638 Gennari, 1985, Comparative effects on bone mineral content of calcium and calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis, Current Therapeutic Research, 38, 455 Gennari, 1984, Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans, Calcif Tissue Int, 36, 245, 10.1007/BF02405325 Girasole, 1992, 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens, J Clin Invest, 89, 883, 10.1172/JCI115668 Graf, 1985, Cortisol and endorphin increase produced by calcitonin administration, Israel Journal of Medical Science, 21, 483 Heath H, 1977, Plasma calcitonin in normal man: Differences between men and women, J Clin Invest, 60, 1135, 10.1172/JCI108865 Herzberg, 1980, Spinal-cord syndrome due to noncompressive Paget’s disease of bone, a spinal artery steal phenomenon reversible with salmon calcitonin, Lancet, 2, 13, 10.1016/S0140-6736(80)92891-3 Hindley, 1982, A double-blind controlled trial of salmon calcitonin in pain due to malignancy, Cancer Chemother, 9, 71, 10.1007/BF00265381 Hutchinson, 1979, Postmenopausal oestrogens protect against fractures of hip and distal radius: A case-control study, Lancet, 2, 705, 10.1016/S0140-6736(79)90640-8 Jenkins, 1969, Osteoporosis: The dramatic effect of disuse of an extremity, Journal of Orthopedic and Related Research, 64, 127 Jones, 1990, Comparison of bone density in amenorrheic women due to athletics, weight loss, and premature menopause, Obstet Gynecol, 66, 5 Joyce, 1990, Osteoporosis in women with eating disorders: Comparison of physical parameters, exercise, and menstrual status with SPA and DPA evaluation, J Nucl Med, 31, 325 Kanis, 1992, Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture, BMJ, 305, 1124, 10.1136/bmj.305.6862.1124 Kroger, 1992, Effect of calcitonin on bone histomorphometry and bone metabolism in rheumatoid arthritis, Calcif Tissue Int, 50, 11, 10.1007/BF00297290 Lyritis, 1991, Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: Double-blind placebo-controlled study, Calcif Tissue Int, 49, 369, 10.1007/BF02555844 MacIntyre, 1988, Calcitonin for prevention of postmenopausal bone loss, Lancet, 1, 900, 10.1016/S0140-6736(88)91712-6 Manolagas, 1979, Adrenal steroids and the development of osteoporosis in oophorectomized women, Lancet, 2, 597, 10.1016/S0140-6736(79)91663-5 Mazzuoli, 1986, Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical study, Calcif Tissue Int, 38, 3, 10.1007/BF02556587 Mazzouli, 1990, Effects of salmon calcitonin on the bone loss induced by ovariectomy, Calcif Tissue Int, 47, 209, 10.1007/BF02555921 Mazess, 1989, Monitoring skeletal response to estrogen, Am J Obstet Gynecol, 161, 843, 10.1016/0002-9378(89)90732-1 Meunier, 1993, Is steroid-induced osteoporosis preventable?, N Engl J Med, 328, 1781, 10.1056/NEJM199306173282411 Minaire, 1987, Immobilization bone loss: Preventive effect of calcitonin in several clinical models, 603 Minaire, 1984, Treatment of acute osteoporosis due to paraplegia with salmon calcitonin, Horm Res, 20, 88 Minaire, 1974, Quantitative histological data on disuse osteoporosis: Comparison with biological data, Calcif Tissue Res, 17, 57, 10.1007/BF02547214 Montemurro, 1991, Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients, Calcif Tissue Int, 49, 71, 10.1007/BF02565124 Muff, 1991, Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of postmenopausal osteoporosis, Osteoporos Int, 1, 72, 10.1007/BF01880446 Naessen, 1990, Hormone replacement therapy and the risk for first hip fracture, Ann Intern Med, 113, 95, 10.7326/0003-4819-113-2-95 Nagant de Deuxchaisnes, 1983, Calcitonin in the treatment of Paget’s disease, Triangle, 22, 103 Nagant de Deuxchaisnes, 1977, Roentgenologic evaluation of the efficacy of calcitonin in Paget’s disease of bone, 213 Overgaard, 1992, Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: A dose-response study, BMJ, 305, 556, 10.1136/bmj.305.6853.556 Overgaard, 1990, Discontinuous calcitonin treatment of established osteoporosis—effects of withdrawal of treatment, Am J Med, 89, 1, 10.1016/0002-9343(90)90089-V Overgaard, 1989, Effect of salcatonin given intranasally on early postmenopausal bone loss, BMJ, 299, 477, 10.1136/bmj.299.6697.477 Pacifici, 1989, Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin-1 release, Proc Natl Acad Sci U S A, 86, 2398, 10.1073/pnas.86.7.2398 Pacifici, 1987, Spontaneous release of interleukin-1 from human blood monocytes reflects bone formation in idiopathic osteoporosis, Proc Natl Acad Sci USA, 84, 4616, 10.1073/pnas.84.13.4616 Pacifici, 1990, Dual energy radiography versus quantitative computer tomography for the diagnosis of osteoporosis, J Clin Endocrinol Metab, 70, 705, 10.1210/jcem-70-3-705 Paul, 1988, Long-term l-thyroxine therapy is associated with decreased hip bone density in premenopausal women, JAMA, 259, 3137, 10.1001/jama.1988.03720210027023 Podenphant, 1987, Bone turnover in spinal osteoporosis, J Bone Miner Res, 2, 497, 10.1002/jbmr.5650020606 Ravichandran, 1981, Spinal cord function in Paget’s disease of the spine, Paraplegia, 19, 7 Reginster, 1987, 1-Year controlled randomized trial in prevention of early postmenopausal bone loss by intranasal calcitonin, Lancet, 2, 1481, 10.1016/S0140-6736(87)92619-5 Reginster, 1989, Relationship between whole plasma calcitonin levels, calcitonin secretory capacity, and plasma levels of estrone in healthy women and postmenopausal osteoporosis, J Clin Invest, 83, 1073, 10.1172/JCI113950 Rico, 1990, Treatment of multiple myeloma with nasal spray calcitonin: A histomorphometric and biochemical study, Bone Miner, 8, 231, 10.1016/0169-6009(90)90108-R Rico, 1992, Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome, Bone Miner, 16, 131, 10.1016/0169-6009(92)90883-F Riggs, 1983, Heterogeneity of involutional osteoporosis: Evidence for two osteoporosis syndromes, Am J Med, 75, 899, 10.1016/0002-9343(83)90860-4 Riis, 1986, The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis, Calcif Tissue Int, 38, 318, 10.1007/BF02555743 Rivkees, 1988, The relationship of gonadal activity and chemotherapy-induced gonadal damage, JAMA, 259, 2123, 10.1001/jama.1988.03720140043031 Rosen, 1994, Specificity of urinary excretion cross-linked N-telopeptides of type 1 collagen as a marker of bone turnover, Calcif Tissue Int, 54, 26, 10.1007/BF00316285 Sambrook, 1993, Prevention of corticosteroid osteoporosis: A comparison of calcium, calcitriol, and calcitonin, N Engl J Med, 328, 1747, 10.1056/NEJM199306173282404 Sammaa, 1986, Calcitonin as treatment in hearing loss in Paget’s disease, Am J Otolaryngol, 7, 241 Schoutens, 1988, Bone loss and bone blood flow in paraplegic rats treated with calcitonin, diphosphonate, and indomethacin, Calcif Tissue Int, 42, 136, 10.1007/BF02556346 Seibel, 1992, Urinary pyridinium crosslinks of collagen specific markers of bone resorption in metabolic bone diseases, Trends in Endocrinology and Metabolism, 3, 263, 10.1016/1043-2760(92)90129-O Silegham, 1992, Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis, Ann Rheum Dis, 51, 761, 10.1136/ard.51.6.761 Spector, 1993, Risk of vertebral fracture in women with rheumatoid arthritis, BMJ, 306, 558, 10.1136/bmj.306.6877.558 Steingold, 1987, Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease, J Clin Endocrinol Metab, 65, 773, 10.1210/jcem-65-4-773 Steingold, 1986, Treatment of severe androgen excess due to ovarian hyperthecosis with a long-acting gonadotropin-releasing hormone agonist, Am J Obstet Gynecol, 154, 1241, 10.1016/0002-9378(86)90706-4 The Ludwig Breast Cancer Study Group, 1988, Combination adjuvant chemotherapy for node-positive breast cancer: Inadequacy of a single perioperative cycle, N Engl J Med, 319, 677, 10.1056/NEJM198809153191104 Wallach, 1993, Effects of calcitonin on bone quality and osteoblastic function, Calcif Tissue Int, 52, 335, 10.1007/BF00310194 Warne, 1973, Cyclophosphamide-induced ovarian failure, N Engl J Med, 289, 1159, 10.1056/NEJM197311292892202 Weiss, 1980, Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen, N Engl J Med, 303, 1195, 10.1056/NEJM198011203032102 Whyte, 1982, Postmenopausal osteoporosis: A heterogeneous disorder as assessed by histomorphometric analysis of iliac crest bone from untreated patients, Am J Med, 72, 193, 10.1016/0002-9343(82)90810-5 Wimalawansa, 1993, Long- and short-term side effects and safety of calcitonin in man: A prospective study, Calcif Tissue Int, 52, 90, 10.1007/BF00308314 Woodhouse, 1977, Paget’s disease: Radiological changes occurring in untreated patients and those on salmon calcitonin therapy during two years’ observation, Br J Radiol, 50, 699, 10.1259/0007-1285-50-598-699 Zseli, 1985, Decreased calcitonin reserve in accelerated postmenopausal osteoporosis, Horm Metab Res, 17, 696, 10.1055/s-2007-1013650